There are only two financial journalists who write regularly about Skinbiotherapeutics (SBTX): myself and Steve Moore. Coverage elsewhere is minimal to zero yet for some reason the company wastes the cash of loyal shareholders such as myself, on Instinctif, a financial PR firm. Yesterday at 4.16PM on trading statement day Mr Phillip Marriage of Instinctif dropped me an email. I suspect he wishes he had not. Our full exchange follows.